Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Gains from Investment Securities (2020 - 2025)

Journey Medical's Gains from Investment Securities history spans 6 years, with the latest figure at $1.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities rose 7088.3% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Dec 2025, up 465.37%, and an annual FY2025 reading of $1.5 million, down 38.93% over the prior year.
  • Gains from Investment Securities for Q4 2025 was $1.5 million at Journey Medical, down from $1.5 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $3.1 million in Q2 2023, with the low at $1000.0 in Q4 2021.
  • Average Gains from Investment Securities over 5 years is $1.2 million, with a median of $1.0 million recorded in 2021.
  • Year-over-year, Gains from Investment Securities skyrocketed 14800.0% in 2022 and then plummeted 95.82% in 2024.
  • Tracing DERM's Gains from Investment Securities over 5 years: stood at $1000.0 in 2021, then skyrocketed by 14800.0% to $149000.0 in 2022, then tumbled by 35.57% to $96000.0 in 2023, then tumbled by 78.12% to $21000.0 in 2024, then skyrocketed by 7088.3% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Gains from Investment Securities are $1.5 million (Q4 2025), $1.5 million (Q3 2025), and $2.8 million (Q2 2025).